T Cells Expressing a Bispecific CAR Targeting CS1 and BCMA in Relapsed/Refractory Multiple Myeloma

Conditions

• CS1+ or BCMA+ Multiple Myeloma

Interventions

• BIOLOGICAL: Conditioning chemotherapy followed by CAR T cell infusion

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborators

• [object Object]